Pharmaceutical Manufacturers

The 2,300 pharmaceutical manufacturers in the US are engaged in researching, developing, manufacturing and marketing chemically-derived drugs and biologicals for human or veterinary use. A few large, multinational firms dominate the industry; but there are also a large number of smaller start-up or development firms, particularly in the biotech segment.

Competition From Generic Products

Branded prescription drugs face competitive challenges from generic pharmaceutical manufacturers.

Expanded Managed Care Influence

Managed Care Organizations (MCOs), Medicaid, and other government agencies continue to seek price discounts on or increased rebates for pharmaceuticals.

Sep 2, 2026 - President Trump Strikes New Drug Pricing Deal

• President Donald Trump announced in late August drug-pricing agreements with nine more pharmaceutical companies. The agreements expand a program that President Trump says will save Americans more than $600 billion and mark the largest drop in prescription drug prices in US history. The nine new companies join 17 larger drugmakers already under agreements, bringing the total to 26 companies covering roughly 90% of the US pharmaceutical market. The nine companies agreed to provide discounts on outpatient drugs to every state Medicaid program so that prices states pay align with what companies charge in foreign countries. The agreements impact drugs that treat several chronic and rare diseases, such as hemophilia, liver disease, skin conditions and certain forms of cancer.
• Fewer than half of Americans (49%) can consistently afford the care and medications they need, according to the latest West Health-Gallup Healthcare Affordability Index. Pharmaceutical manufacturers may be negatively impacted by decreasing health care affordability. The share of adults who are “cost secure” has decreased from a 2022 peak of 61%, and an estimated 2.8 million more people fell out of that category between 2024 and 2025 alone. Cost insecurity now reaches groups long considered insulated: just 61% of adults 65 and older are cost secure, down from 73% in 2021.
• Only 17% of pharmaceutical industry organizations surveyed by data security firm Kiteworks have implemented automated controls to prevent sensitive data from leaking through AI tools. The remaining 83% depend on human-centered approaches: Forty percent rely on employee training sessions and periodic audits, essentially hoping staff will remember and follow the rules when working under pressure. Another 20% send warning emails about AI usage but never verify compliance. Ten percent have only issued guidelines, while 13% have no policies whatsoever. These organizations — including many contract development and manufacturing organizations — operate without basic technical safeguards while their employees paste molecular structures, clinical trial results, and patient records into ChatGPT, Claude, Perplexity, and other AI platforms, according to Kiteworks.
• Pharmaceutical manufacturing industry employment and wages for nonsupervisory employees increased slightly during the first five months of 2026, according to the US Bureau of Labor Statistics (BLS). Pharmaceutical manufacturers kept prices unchanged during the first six months of 2026, according to the BLS.

Industry size & Structure

An average pharmaceutical manufacturer generates about $102.5 million in annual revenue and has about 152 employees.

• The pharmaceutical manufacturing industry consists of about 2,300 companies with $236 billion in sales and 350,500 employees.
• A few large, multinational firms dominate the industry, but there is also a large number of smaller, start-up, or development firms, particularly in the biotech segment.
• Large pharmaceutical manufacturers include Pfizer, Merck, Johnson & Johnson, Eli Lilly, and Bristol-Myers Squibb.
• The states with the highest number of pharmaceutical manufacturers are California, New Jersey, New York, Florida and Texas.
• The largest concentration of biotech firms are in California, Texas, Pennsylvania, Massachusetts, and Wisconsin.